[Federal Register Volume 65, Number 207 (Wednesday, October 25, 2000)]
[Notices]
[Pages 63890-63891]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-27427]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 23, 2000, and published in the Federal 
Register on March 30, 2000, (65 FR 16963), Lilly Del Caribe, Inc., 
Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, Puerto Rico 
00680, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
dextropropoxyphene (9273), a basic class of controlled substance listed 
in Schedule II.
    The firm plans to bulk manufacture product for distribution to its 
customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Lilly Del Caribe, Inc., to 
manufacture dextropropoxyphene is consistent with the public interest 
at this time. DEA has investigated Lilly Del Caribe, Inc. on a regular 
basis to ensure that the company's continued registration is consistent 
with the public interest. This investigation included inspection and 
testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed above is granted.


[[Page 63891]]


    Dated: October 16, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-27427 Filed 10-24-00; 8:45 am]
BILLING CODE 4410-09-M